Back to results
US 2015/0306182 A1Published application
Fat loss composition
OwnerPeter KENNY, Darren DAVEYinventors
Life of this patent
Estimating the term…
Abstract
Disclosed is a fat loss composition comprising a) a prostaglandin F2alpha analogue, such as cloprostenol, or a pharmaceutically acceptable ester or salt thereof; and b) amino acids 176-191 of human growth hormone. Use of the composition in weight loss, weight management and/or slimming is described.
Claims11
A fat loss composition comprising:
- a) a prostaglandin F2alpha analogue or a pharmaceutically acceptable ester or salt thereof;
- and
- b) amino acids 176-191 of human growth hormone,
- for use in weight loss, weight management and/or slimming.
1 more element
Dependencies are inferred from the claim text.